Correlation Of Bone Turnover Markers With Age, BMI And Serum Oestradiol In Pre And Postmenopausal Urban Women
Bone Turnover Markers and Serum Oestradiol In Pre And Postmenopausal Women
DOI:
https://doi.org/10.70284/njirm.v6i2.884Keywords:
Osteocalcin, Telopeptide-C, Postmenopausal womenAbstract
Background: Rapid bone loss occurs in women after menopause due to hormonal factors that lead to an increased susceptibility to fractures. This study was done to find out the correlation of osteocalcin and telopeptide-C with age, body mass index (BMI) and oestradiol in premenopausal and postmenopausal women. Methodology: Study was conducted on 350 women aged 30–65 years who were classified into premenopausal and postmenopausal groups. Serum samples were analysed for oestradiol, osteocalcin and telopeptide-C. Pearsons correlation was used for statistical confirmations. Results: Osteocalcin was found to be correlated with age (r= +0.56, p<0.001), BMI (r= -0.39, p<0.001), oestradiol (r= -0.21, p<0.01) and telopeptide-C (r= +0.18, p<0.05) in postmenopausal women but no correlation was found in premenopausal women. Telopeptide-C was found to be correlated with age (r= +0.39,p<0.001), BMI (r= -0.29,p<0.001) and oestradiol (r= -0.48,p<0.001) in postmenopausal women; in premenopausal women it was found to be correlated with BMI (r= -0.30,p<0.001) and oestradiol (r= -0.29,p<0.001). Conclusion: Inverse correlation of Telopeptide-C with BMI and serum oestradiol in premenopausal and postmenopausal women suggests that their increased bone turnover was linked to low BMI and oestrogen deficiency.[Jain V NJIRM 2015; 6(2):66-69]
References
2. Ensurd KE, Palermo L, Black DM, et al. Hip and calcaneous bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 1995;10:1778–1787.
3. Warming L, Hassager C, Christiansen C. Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporosis Int. 2002;13(2):105-12.
4. Susan A. Calcium Supplementation in Postmenopausal Women. From Medscape Ob/Gyn & Women’s health. 2003; 8(2).
5. Manolagos SC, Jilka RL. Bone marrow, cytokines and bone remodelling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305–11.
6. Unni J, Garg R, Pawar R. Bone mineral density in women above 40 years. J Midlife Health. 2010;1(1):19–22
7. Sharma S and Khandelwal S. Effective risk assessment tools for osteoporosis in the Indian menopausal female. J Midlife Health. 2010;1(2):79–85.
8. Rosen CJ, Rackoff PJ: Emerging anabolic treatment for osteoporosis. Rheum Dis Clin North Am. 2001; 27: 215–233
9. Miller PD, Zapalowski C, Kulak CAM, et al. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrin Metab 1999;84:1867–1871.
10. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J . The Use of Biochemical Markers of Bone Turnover in Osteoporosis. Osteoporos Int. 2000; Suppl 6: S2-17.
11. Woitge HW, Nave CS, Kissing C, Bruckner GL, Meyer K, Grauer A, et al. Seasonal Variation of Biochemical Indexes of Bone Turnover; Results of a population-based Study. J Clin Endocrinol Metab. 1998; 92(1): 68-75.
12. Melton III LJ, Khosla S, Atkinson EJ, O’Fallon WM, Riggs BL: Relationship of bone turnover to bone density and fractures. J Bone Miner Res. 1997; 12: 1083–1091.
13. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:827–34.
14. Lateef M, Baig M, Azhar A. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females. Osteoporos Int .2010; 21:751–755.
15. Garnero P, Borel O, Delmas PD. Evaluation of a Fully Automated Serum Assay for C-Terminal Cross-Linking Telopeptide of Type I Collagen in Osteoporosis. Clinical Chemistry 2001;47(4): 694–702
16. Heany RP, Recker RR, Saville RP. Menopausal changes in bone remodeling. J Lab Clin Med 1978;92:964–70. 17. Younes M, et al. Utility of biochemical markers of bone turnover in diagnosis of osteoporosis and fracture risk prediction. Tunis Med. 2014 May;92(5):304-10. 18. Bhattarai T, Bhattacharya K, Chaudhuri P, Sengupta P. Correlation of Common Biochemical Markers for Bone Turnover, Serum Calcium, and Alkaline Phosphatase in Post-Menopausal Women. Malays J Med Sci. 2014 Jan; 21(1): 58–61.
19. Lie T. Merijanti Susanto. Serum osteocalcin and bone mineral density in postmenopausal women. Universa medicina. September-December, 2011 Vol.30 - No.3
20. Jain V, Agrawal BK, Varshney A, Biswas S. Prediction of bone mineral density by age,
body mass index and menopausal status in middle socioeconomic status women of urban Kolar region of Bhopal. IOSR Journal of Dental and Medical Sciences 2013; 12(3),17-21 21. Johansson H1 et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014 Jan;29(1):223-33. 22. Luigi M, Loredana M. Utility of dietary phytoestrogen in preventing postmenopausal osteoporosis. Curr Topics in Nutraceutical Res 2005;(3)15–28. 23. Ohta H, Sugimoto I, Masuda A, Komukai S, Suda Y, Makita K, et al. Decrease bone mineral density associated early menopause progress for at least ten years: cross-sectional comparison between early and normal menopausal women. Bone 1996;18(3):227–31.
24. Studd JWW. Management of premature ovarian failure. In: Ring EJF, Elvins DM, Bhalla, AK, eds. Current research in osteoporosis and bone mineral measurement IV: 1996 Conference Proceedings [abstract].
25. Gundberg CM, Nishimoto SK (1999) Vitamin K dependent proteins of bone and cartilage. In: Seibel MJ, Robbins SP, Bilezikian JP (eds) Dynamics of bone and cartilage. Metabolism Academic, San Diego, pp 43–58
